Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Whitehawk Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +1 vs. Q1 2021
- Shares held
- 30.2M
- +3.64M (+13.7%) vs. Q1 2021
- Total value
- $51.0M
- +$16.8M (+48.9%) vs. Q1 2021
- New holders
- 12
- 7 more added
- Sold out
- 11
- 11 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 201 | $0 | 0.00% | −2,965−93.7% | Reduced |
| Bank of America Corp | 241 | $0 | 0.00% | −1,759−87.9% | Reduced |
| O'Shaughnessy Asset Management, LLC | 228 | $0 | 0.00% | −135−37.2% | Reduced |
| Parallel Advisors, LLC | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,213 | $2.00K | 0.00% | −1−0.1% | Reduced |
| NEXT Financial Group, Inc | 1,500 | $3.00K | 0.00% | +1,500 | New |
| Advisor Group Holdings, Inc. | 2,700 | $5.00K | 0.00% | +1,200+80.0% | Added |
| Lindbrook Capital, LLC | 5,000 | $8.00K | 0.00% | +5,000 | New |
| Truepoint, Inc. | 10,219 | $17.0K | 0.00% | 00.0% | Unchanged |
| Ascent Wealth Partners, LLC | 10,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 15,017 | $25.0K | 0.00% | +15,017 | New |
| Dimensional Fund Advisors LP | 15,393 | $26.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 17,331 | $29.0K | 0.01% | +17,331 | New |
| Two Sigma Advisers, LP | 20,300 | $34.0K | 0.00% | +7,500+58.6% | Added |
| Virtu Financial LLC | 46,869 | $79.0K | 0.01% | −35,437−43.1% | Reduced |
| CSS LLC | 50,000 | $84.0K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 50,000 | $85.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 55,602 | $94.0K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 56,947 | $96.0K | 0.00% | −21,145−27.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 58,100 | $98.0K | 0.00% | −13,400−18.7% | Reduced |
| Millennium Management LLC | 74,008 | $125.0K | 0.00% | +74,008 | New |
| Atom Investors LP | 79,996 | $135.0K | 0.03% | +79,996 | New |
| J. Goldman & Co LP | 94,500 | $160.0K | 0.01% | +94,500 | New |
| Neville Rodie & Shaw Inc | 100,000 | $169.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 127,850 | $216.0K | 0.00% | +127,850 | New |
| Rock Springs Capital Management LP | 133,375 | $225.0K | 0.00% | +133,375 | New |
| Boothbay Fund Management, LLC | 208,674 | $353.0K | 0.01% | −94,275−31.1% | Reduced |
| BlackRock Inc. | 241,097 | $407.0K | 0.00% | +115,727+92.3% | Added |
| Price T Rowe Associates Inc | 253,700 | $429.0K | 0.00% | 00.0% | Unchanged |
| Johnson Investment Counsel Inc | 320,536 | $542.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 326,403 | $551.0K | 0.00% | +67,429+26.0% | Added |
| Parkman Healthcare Partners LLC | 353,957 | $598.0K | 0.13% | −647,232−64.6% | Reduced |
| ABG Innovation Capital Partners III GP Ltd | 400,000 | $676.0K | 2.26% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,454,158 | $2.46M | 0.00% | +1,331,388+1,084.5% | Added |
| Acadian Asset Management LLC | 1,572,543 | $2.66M | 0.01% | −338,935−17.7% | Reduced |
| Ikarian Capital, LLC | 1,676,093 | $2.83M | 0.51% | −975,000−36.8% | Reduced |
| Vanguard Group Inc | 1,774,463 | $3.00M | 0.00% | +49,256+2.9% | Added |
| Renaissance Technologies LLC | 2,584,347 | $4.37M | 0.01% | +642,809+33.1% | Added |
| Ra Capital Management, L.P. | 2,693,309 | $4.55M | 0.07% | +2,693,309 | New |
| Avoro Capital Advisors LLC | 4,500,000 | $7.61M | 0.13% | +4,500,000 | New |
| OrbiMed Advisors LLC | 5,193,946 | $8.78M | 0.09% | 00.0% | Unchanged |
| Satter Management Co., L.P. | 5,621,835 | $9.50M | 5.16% | 00.0% | Unchanged |
| Heritage Wealth Management, LLC | 3 | – | – | +3 | New |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −2,072,782−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Scion Asset Management, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Keudell/Morrison Wealth Management | 0 | $0 | 0.00% | −30,694−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,019−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,581−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,835−100.0% | Sold out |
| Lakeview Capital Partners, LLC | 0 | $0 | 0.00% | −12,722−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,016−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −11,648−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,288−100.0% | Sold out |